Science Publications

Sign Up
Sign In
Submit
Current Research in Public Health
Cite This Article Share Download PDF XML
  1. Home
  2. Journals
  3. Current Research in Public Health
  4. Archive
  5. Volume 4, Issue 2, 2024
  6. Article
Article Open Access November 16, 2024

Digital Therapeutics: A New Dimension to Diabetes Mellitus Management

Raju Rhee 1, Rahul K Jaiswal 2 and Gunjan Lath 3,*
1
Tata Institute of Social Sciences, Mumbai, India
2
ICARE Institute of Medical Science and Research, India
3
Rajiv Gandhi University of Health Sciences, Karnataka, India
Publihed in: Current Research in Public Health (Volume 4, Issue 2, 2024)
Page(s): 74-81
DOI: 10.31586/jaibd.2024.1090
Received
August 15, 2024
Revised
September 29, 2024
Accepted
November 14, 2024
Published
November 16, 2024
Keywords
Digital Therapeutics; Digital Health; Software as a Medical Device (SaMD); Healthcare Digitization; Technology in Healthcare
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2024. Published by Scientific Publications
Article metrics
Views
369
Downloads
90

Cite This Article

APA Style
Rhee, R. , Jaiswal, R. K. , & Lath, G. (2024). Digital Therapeutics: A New Dimension to Diabetes Mellitus Management. Current Research in Public Health, 4(2), 74-81. https://doi.org/10.31586/jaibd.2024.1090
ACS Style
Rhee, R. ; Jaiswal, R. K. ; Lath, G. Digital Therapeutics: A New Dimension to Diabetes Mellitus Management. Current Research in Public Health 2024 4(2), 74-81. https://doi.org/10.31586/jaibd.2024.1090
Chicago/Turabian Style
Rhee, Raju, Rahul K Jaiswal, and Gunjan Lath. 2024. "Digital Therapeutics: A New Dimension to Diabetes Mellitus Management". Current Research in Public Health 4, no. 2: 74-81. https://doi.org/10.31586/jaibd.2024.1090
AMA Style
Rhee R, Jaiswal RK, Lath G. Digital Therapeutics: A New Dimension to Diabetes Mellitus Management. Current Research in Public Health. 2024; 4(2):74-81. https://doi.org/10.31586/jaibd.2024.1090 
@Article{crph1090,
AUTHOR = {Rhee, Raju and Jaiswal, Rahul K and Lath, Gunjan},
TITLE = {Digital Therapeutics: A New Dimension to Diabetes Mellitus Management},
JOURNAL = {Current Research in Public Health},
VOLUME = {4},
YEAR = {2024},
NUMBER = {2},
PAGES = {74-81},
URL = {https://www.scipublications.com/journal/index.php/JAIBD/article/view/1090},
ISSN = {2831-5162},
DOI = {10.31586/jaibd.2024.1090},
ABSTRACT = {Digital therapeutics (DTx) play a transformative role in diabetes management by leveraging technology to provide personalized, data-driven medical interventions. These tools enhance self-management by offering continuous monitoring and real-time feedback on glucose levels, diet, and physical activity. This personalized approach helps patients adhere to treatment plans and make informed lifestyle changes, leading to improved clinical outcomes such as reduced HbA1c levels and better overall diabetes control. The importance of DTx lies in their ability to make diabetes care more accessible and convenient. Mobile apps and telemedicine platforms enable patients to receive support and guidance from anywhere, reducing the need for frequent in-person visits. Additionally, DTx often include behavioral support features like reminders, educational content, and motivational tools, which are crucial for maintaining healthy habits and managing stress. Currently, the dynamics of DTx in diabetes are rapidly evolving, with increasing integration of artificial intelligence and machine learning to further personalize and optimize care. As the adoption of these technologies grows, they hold the potential to significantly improve patient outcomes and revolutionize diabetes management on a global scale. This article will focus on the benefits of novel digital therapeutics for prevention and management of type II diabetes that are currently available in the market.},
}
%0 Journal Article
%A Rhee, Raju
%A Jaiswal, Rahul K
%A Lath, Gunjan
%D 2024
%J Current Research in Public Health

%@ 2831-5162
%V 4
%N 2
%P 74-81

%T Digital Therapeutics: A New Dimension to Diabetes Mellitus Management
%M doi:10.31586/jaibd.2024.1090
%U https://www.scipublications.com/journal/index.php/JAIBD/article/view/1090

TY  - JOUR
AU  - Rhee, Raju
AU  - Jaiswal, Rahul K
AU  - Lath, Gunjan
TI  - Digital Therapeutics: A New Dimension to Diabetes Mellitus Management
T2  - Current Research in Public Health
PY  - 2024
VL  - 4
IS  - 2
SN  - 2831-5162
SP  - 74
EP  - 81
UR  - https://www.scipublications.com/journal/index.php/JAIBD/article/view/1090
AB  - Digital therapeutics (DTx) play a transformative role in diabetes management by leveraging technology to provide personalized, data-driven medical interventions. These tools enhance self-management by offering continuous monitoring and real-time feedback on glucose levels, diet, and physical activity. This personalized approach helps patients adhere to treatment plans and make informed lifestyle changes, leading to improved clinical outcomes such as reduced HbA1c levels and better overall diabetes control. The importance of DTx lies in their ability to make diabetes care more accessible and convenient. Mobile apps and telemedicine platforms enable patients to receive support and guidance from anywhere, reducing the need for frequent in-person visits. Additionally, DTx often include behavioral support features like reminders, educational content, and motivational tools, which are crucial for maintaining healthy habits and managing stress. Currently, the dynamics of DTx in diabetes are rapidly evolving, with increasing integration of artificial intelligence and machine learning to further personalize and optimize care. As the adoption of these technologies grows, they hold the potential to significantly improve patient outcomes and revolutionize diabetes management on a global scale. This article will focus on the benefits of novel digital therapeutics for prevention and management of type II diabetes that are currently available in the market.
DO  - Digital Therapeutics: A New Dimension to Diabetes Mellitus Management
TI  - 10.31586/jaibd.2024.1090
ER  -